Latest News in the pharma Industry

Research & Development

Nintedanib Receives Positive CHMP Opinion in European Union for the Treatment of Idiopathic Pulmonary Fibrosis

Nintedanib Receives Positive CHMP Opinion in European Union for the Treatment of Idiopathic Pulmonary Fibrosis

25 Nov 2014

Read more 
Amgen Terminates All Amgen-Sponsored Clinical Studies of Rilotumumab in Advanced Gastric Cancer

Amgen Terminates All Amgen-Sponsored Clinical Studies of Rilotumumab in Advanced Gastric Cancer

24 Nov 2014

Read more 
Novartis Cosentyx Receives Positive CHMP Opinion for First-Line Treatment of Moderate-to-Severe Psoriasis Patients?

Novartis Cosentyx Receives Positive CHMP Opinion for First-Line Treatment of Moderate-to-Severe Psoriasis Patients?

21 Nov 2014

Read more 
Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

Regeneron and Sanofi Announce that Dupilumab Has Received FDA Breakthrough Therapy Designation in Atopic Dermatitis

20 Nov 2014

Read more